Peter Alexander Smethurst

Title: Peter Alexander Smethurst: Innovator in Human Antibodies

Introduction

Peter Alexander Smethurst is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of biotechnology, particularly in the development of human antibodies. With a total of 2 patents, his work focuses on innovative solutions for diagnosing and treating blood conditions.

Latest Patents

Smethurst's latest patents include groundbreaking research on human antibodies against human glycoprotein VI. His patent titled "Specific binding members directed to human glycoprotein VI (GPVI)" describes the use of the antibody VH and/or VL domain of the scFv fragment termed 10B12. This invention showcases the ability of these antibodies to inhibit collagen-induced platelet aggregation and the adhesion of platelets to Collagen-Related Peptide (CRP). Additionally, he has developed methods for diagnosing abnormal blood conditions based on polymorphisms in the glycoprotein VI gene. These methods are crucial for identifying individuals at increased risk of bleeding, particularly those who are homozygous or heterozygous for the GPVI allele.

Career Highlights

Throughout his career, Smethurst has worked with esteemed institutions, including the University of Cambridge. His research has led to advancements in understanding blood disorders and the development of diagnostic kits for various medical conditions. His innovative approach has garnered attention in the scientific community.

Collaborations

Smethurst has collaborated with notable professionals in his field, including Willem Ouwehand and Richard William Farndale. These partnerships have contributed to the success of his research and the impact of his inventions.

Conclusion

Peter Alexander Smethurst is a distinguished inventor whose work in human antibodies has the potential to revolutionize the diagnosis and treatment of blood conditions. His contributions to biotechnology continue to influence the medical field significantly.